Clinical Trials Logo

Clinical Trial Summary

Small vascular malformations (SVM) on the vocal fold is a common problem that can disturb the voice. The pulsed dye laser (PDL) has been successfully used for treatment of blood vessel abnormalities in surface tissue, through its high selectivity for destroying targeted blood vessels while sparing normal tissue. However, there is no study to determine its clinical benefit for treatment of SVMs on vocal fords. In this proposed study, we plan to make such a determination.We will determine whether PDL will produce better and quicker voice improvement than the conventional surgeries, in 20 patients (10 cases of each group) with vocal fold SVM. We expect that this less invasive laser treatment will provide an ideal and excellent option for this disease.


Clinical Trial Description

Clinically, small vascular malformations (SVM) on the vocal fold is a common problem that can disturb the voice. Currently, this problem is treated with endoscopic microsurgery with the use of a Carbon dioxide (CO2) laser or other microsurgeries. However, those treatments are unsatisfactory because of their invasive nature. The pulsed dye laser (PDL) has been successfully used for treatment of blood vessel abnormalities in surface tissue, through its high selectivity for destroying targeted blood vessels while sparing normal tissue. Even thought this process has been in use clinically for the past 5 years, there is no study to determine its clinical benefit for treatment of SVMs on vocal fords, by comparing it with routine surgeries. In this proposed study, we plan to make such a determination, by comparing the voice recovery and voice improvement between this laser and those routine surgeries (with CO2 laser or "cold" instrument).

Our specific aim is to determine whether PDL will produce better and quicker voice improvement than the conventional surgeries, in 20 patients (10 cases of each group) with vocal fold SVM. This is the first study to determine clinical benefit of the microvascular targeting (MVT) technique of laser to treat vocal fold SVMs, by a comparison of the voice results between these two groups. We expect that this less invasive laser treatment will provide an ideal and excellent alternative to current surgical approaches for treatment of this disease. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00592644
Study type Interventional
Source Boston University
Contact
Status Completed
Phase Phase 2
Start date March 2005
Completion date October 2008

See also
  Status Clinical Trial Phase
Recruiting NCT05051917 - The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome
Withdrawn NCT01789333 - Higher Irradiance in Keratoconus Ectasia N/A
Terminated NCT01024322 - Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Not yet recruiting NCT03858036 - Corneal Collagen Cross-Linking (CXL) Performed With "Epi-ON" Versus "Epi-OFF" in Eyes With Keratoconus and Other Corneal Ectatic Disorders Phase 3
Completed NCT02131740 - Eye Rubbing and Transient Change in Corneal Parameters N/A
Recruiting NCT01325298 - UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia Phase 2
Active, not recruiting NCT03080077 - Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia Phase 3
Recruiting NCT02118922 - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Enrolling by invitation NCT01081561 - Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs Phase 2/Phase 3
Completed NCT00004327 - Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia Phase 2
Terminated NCT01189864 - Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Terminated NCT01398839 - Safety Study of the VEGA UV-A System to Treat Ectasia Phase 3
Completed NCT00674661 - Corneal Collagen Cross-Linking for Ectasia (CXL) Phase 3
Completed NCT04649177 - Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting N/A
Completed NCT03896321 - Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management N/A
Terminated NCT01097447 - Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Completed NCT02008253 - Intrastromal Corneal Ring for Ectasia After Refractive Surgery (Anel) N/A
No longer available NCT01384773 - Progressive Keratoconus or Ectasia Treatment Plan